OBJECTIVES: A single MitraClip implant is often considered enough to achieve adequate mitral regurgitation (MR) reduction. The aim of this study was to compare MR recurrence in patients with an initial optimal result treated with a single clip versus those treated with two clips.
INTRODUCTION
Transcatheter mitral repair with the MitraClip procedure has emerged over the last decade as a valid option to treat high-risk, inoperable symptomatic patients affected by mitral regurgitation (MR) [1, 2] .
Currently, the biggest drawback of transcatheter mitral repair remains its suboptimal efficacy in terms of MR reduction, which in turn is associated with impaired follow-up outcomes [3] [4] [5] . Of note, disappointing repair durability with a high early recurrence rate of MR has been reported in patients with initial 'optimal' results (residual MR < _1+ after the procedure) [6] . Different mechanisms can lead to MR recurrence after the MitraClip procedure, such as partial clip detachment, progression of prolapse disease, annular dilatation and progression of left ventricular remodelling.
Usually, when the implantation of a single clip provides good reduction in MR, the procedure is completed. Indeed, 60% of all patients treated with the MitraClip procedure receive only a single clip [3, 4, 7] .
Achieving an optimal, durable reduction in MR is today the main goal of all transcatheter mitral technologies. This is fundamental before expanding the indications for using transcatheter devices in lower risk patients. Bearing this target in mind and the recurrence mechanisms described above, one may express concern regarding the durability of transcatheter mitral repair with a single clip because specific data are currently lacking in the literature.
The purpose of our study was to determine whether the reduction in MR after the implant of a single clip was as durable as the reduction achieved with 2 clips, in patients with an initial optimal result (MR < _1+).
METHODS
Between October 2008 and May 2016, 322 consecutive patients were treated with the MitraClip procedure at the Cardiac Surgery Department of the San Raffaele Scientific Institute. All patients were symptomatic and were deemed to be at increased surgical risk. The heart team adjudicated surgical risk using the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) as well as other factors uncaptured by the STS-PROM (patent grafts, porcellain aorta and frailty).
All in-hospital data were prospectively collected, and all patients were enrolled in a dedicated echocardiographic outpatient clinic, with scheduled follow-up examinations at 1 month, 6 months, 12 months and yearly thereafter.
All patients had a transoesophageal echocardiogram before implantation and a transthoracic echocardiogram before discharge as well as at every follow-up visit. Although EVEREST II eligibility criteria were initially used as a reference [8] , patients who did not meet these criteria were also routinely treated and included in the present study. Exclusion criteria for MitraClip implantation were calcifications involving the target leaflets, multisegmental prolapse, leaflet perforation, active endocarditis and contraindication to perform transoesophageal echocardiography. MR was graded on a 4-grade scale as 1+ (mild), 2+ (moderate), 3+ (moderate-to-severe) and 4+ (severe), according to the current European Association of Echocardiography recommendations [9] . Owing to the potential inaccuracy of the conventional parameters for MR quantification in the setting of subverted mitral valve anatomy (double orifice), the jet-related parameters (vena contracta and effective regurgitant orifice) were used only in the presence of a single-orifice regurgitant jet, whereas the regurgitant fraction (difference between mitral inflow and aortic outflow stroke volume) [10] was used with multiple-jet MR. Patients who did not present to our outpatient clinic were reached by telephone calls and were asked to provide a recent (<6 months) echocardiogram.
We retrospectively reviewed our experience comparing outcomes of patients treated with the MitraClip procedure who had an optimal initial result (residual MR < _ 1+) and who received a single clip or 2 clips. Patients treated with >2 clips were excluded because they were likely to have much more difficult valves and/ or complicated procedures in comparison with those who received a single clip. Patients affected by aetiologies other than functional MR (FMR) or degenerative MR (DMR) were excluded.
The primary endpoint of the study was freedom from MR > _3+ recurrence during the follow-up period, assessed separately in those with FMR and in those with DMR.
Statistical analysis was conducted using the SPSS Statistics software v20 (IBM Corp. Armonk, NY, USA). The distribution of variables was evaluated using the one-sample Kolmogorov-Smirnov test. Continuous variables are presented as the mean ± standard deviation for data with a normal distribution or as the median (25th and 75th percentile limits in brackets) for data with a non-Gaussian distribution. Categorical variables are expressed as proportions. Univariable comparisons have been performed using the paired ttest for normally distributed data. For non-normally distributed data, the Wilcoxon signed rank test was used for paired continuous and the Mann-Whitney test for unpaired continuous variables. The v 2 test was used for categorical data and the Fisher's exact test was used when the minimum cell size requirements for the v 2 test were not satisfied. Long-term survival and freedom from MR were evaluated using the Kaplan-Meier curve. The Cox hazard model was used to predict follow-up outcomes. The hazard ratio (HR) of continuous variables is expressed as 'per unit'; numbers in brackets denote the confidence interval (CI). A CI of 95% was used. A 2-sided P-value <0.05 was considered statistically significant.
RESULTS
A total of 198 patients were included in the study. FMR was observed in 144 and DMR in 54 cases. A single clip was implanted in 45 (31.2%) of those with FMR and in 24 (44.4%) of those with DMR (P = 0.10).
Major preoperative patient characteristics are summarized in Tables 1 and 2 .
FMR group
In patients with FMR, coaptation depth, absolute intercommissural jet extension and mitral valve area (MVA) as well as left atrium volume and left ventricle end-diastolic diameter were all significantly smaller in patients who received a single clip compared with those who received 2 clips.
Mild post-procedural MR was observed in 30 (66.7%) vs 75 (75.8%) of patients in the single clip vs 2 clips group, respectively (P = 0.25; Table 3 ). The residual MVA was 2.8 ± 0.5 in patients with single clip vs 2.6 ± 0.6 cm 2 in those with 2 clips (P = 0.03); MVA <2.5 cm 2 was found in 14.7% vs 38.5% of patients, respectively (P = 0.015).
The median follow-up time was 2.0 (1.0-4.7) vs 1.7 (1.0-4.6) years in the single clip vs the 2 clips group, respectively (P = 0.47). At 30 days, 5 deaths had occurred, all in the 2 clips group (P = 0.12). After 4 years, the Kaplan-Meier freedom from allcause mortality was 84.7 ± 5.8 vs 70.5 ± 5.9 (P = 0.21); freedom from cardiac death was 87.0 ± 5.6 vs 79.1 ± 5.7 (P = 0.90); and freedom from heart failure was 60.5 ± 9.3 vs 54.6 ± 7.9 (P = 0.87) in the single clip vs 2 clips groups, respectively. At the last followup, NYHA Class III-IV was observed in 17.5% of patients with single clip vs 16.5% of those with 2 clips (P = 0.88).
Residual MVA <2.5 cm 2 was not associated with increased allcause mortality (HR 0.59, CI 0.22-1.29, P = 0.30), cardiac mortality (HR 0.37, CI 0.08-1.66, P = 0.19), heart failure recurrence (HR 1.35, CI 0.64-2.85, P = 0.42) or NYHA Class III-IV rate at the last follow-up examination (P = 0.21). Similar results were achieved when we assessed residual MVA as a continuous variable.
In the FMR subgroup, freedom from MR > _ 3+ after 4 years was 71.9 ± 8.9% in patients with a single clip vs 88.0 ± 5.2% in those with 2 clips (P = 0.016; Fig. 1 ). On Cox regression, implantation of a single clip (HR 3.48, CI 1.24-9.81, P = 0.018) and a lower preoperative ejection fraction (HR 0.93, CI 0.87-0.99, P = 0.35) were independent predictors of increased recurrence of MR (Table 4 ).
In the FMR group, 1 partial clip detachment (PCD) was observed before discharge from the hospital in a patient with a single clip; it caused severe MR recurrence and was treated with an immediate re-MitraClip procedure. Two other patients (both in the single clip group) had a re-MitraClip procedure (after 1 year and 5 years) due to severe recurrence of symptomatic MR. Four patients had surgery during the follow-up period: 1 single clip patient required mitral replacement due to MR recurrence 4 months after the procedure; 3 patients (1 single clip and 2 two clips) required left ventricular assist device implants due to progressive heart failure (5, 6 and 16 months after the procedure).
DMR group
Patients with a single clip showed smaller leaflet prolapses, with a general trend towards more favourable valve anatomy in several parameters, although statistical significance was only clearly reached in flail gap (Table 2) .
Mild acute residual MR was similar between the 2 groups (Table 3) . Residual MVA was 2.9 ± 0.3 in patients with a single clip vs 2.6 ± 0.4 cm 2 in those with 2 clips (P = 0.07), with MVA < 2.5 cm 2 found in 4.5% vs 27.3% of patients, respectively (P = 0.039). Median follow-up time was 2.6 (1.3-4.5) vs 1.7 (1.1-2.8) years in patients with a single clip vs those with 2 clips, respectively (P = 0. 19) . No deaths occurred during the 30 days after the operation. After 2 years, the Kaplan-Meier freedom from all-cause mortality was 91.7 ± 5.6 vs 79.7 ± 9.6 in patients with a single clip vs those with 2 clips (P = 0.41). Only 2 cardiac deaths (1 in each group) and 7 recurrences of heart failure (5 in the single clip, 2 in the two clips group) were observed. At the last follow-up examination, NYHA Class III-IV was found in 7 patients (5 in the single clip, 2 in the two clips group). Residual MVA <2.5 cm 2 (HR 3.65, CI 0.96-13.89, P = 0.07) as well as continuous variable (HR 0.19, CI 0.03-1.42, P = 0.11) was not significantly associated with increased all-cause mortality.
In the DMR subgroup, freedom from MR > _3+ after 2 years was 82.5 ± 8% in patients with a single clip vs 100% in those with 2 clips (P = 0.014; Fig. 2 ). Due to the small number of observed events, with no event at all observed in patients with 2 clips, Cox regression analysis for differences in MR recurrence rate in patients with single clip vs those with 2 clips was not conducted. PCD was observed in 4 patients, all cases occurring within the first 6 months after the procedure: 3 patients with a single clip experienced severe MR recurrence and 1 patient with two clips had MR progression to moderate degree. One patient with a single clip had a re-MitraClip procedure (2 years after the index procedure, due to severe MR caused by progression of leaflet prolapse). One patient with a single clip underwent mitral replacement due to early PCD.
DISCUSSION
The main finding of our study was that the implantation of a single clip was associated with faster recurrence of MR compared with the implantation of 2 clips, both in patients with FMR and in those with DMR.
We purposely selected patients in whom the MitraClip had performed well acutely, giving an 'optimal' result, i.e. MR < _1+ at the end of the procedure. As anticipated, patients with single clip actually had a valve with favourable anatomical characteristics: less tethered valve leaflets, smaller leaflet prolapses, narrower jets and smaller MVA. In FMR, they also had less pronounced heart remodelling with smaller left ventricle size, actually showing a less advanced stage of heart disease.
Despite their 'optimal' initial result and the favourable anatomical characteristics, patients who received a single clip experienced a disappointing recurrence rate of MR of 30% after 4 years in those with FMR and 20% after 2 years in those with DMR, which was significantly faster compared with patients who received 2 clips.
The PCD rate was low but not negligible. Although the numbers were too small to draw statistically significant definitive conclusions, PCD was observed more frequently in patients with a single clip than in those with 2 clips, which may help to explain in part the higher recurrence of MR. Indeed, if detachment occurs following implantation of a single clip, recurrence of MR is inevitable. The implantation of a second clip not only stabilizes the whole complex but also reduces the chances of severe MR recurrence in case one of the clips detaches. A single clip that is 'shaky' after implantation should be checked closely and implantation of a second clip should be considered if grasping is suboptimal. Residual untreated valve disease is the other major factor involved in MR recurrence. In FMR, leaflet coaptation can be temporarily but misleadingly improved, and MR can be reduced by increased contractility and reduced ventricular preload and afterload using inotropic agents, an intra-aortic balloon pump and aggressive diuretic therapy. Careful evaluation of the preoperative diagnostic echocardiographic images may help to guide the need for implantation of multiple clips in such cases. In DMR, small residual leaflet prolapse, although it may not cause significant MR at the time of the procedure, can typically progress over time due to ongoing valve disease or can recur due to ventricular reverse remodelling, with significant MR comeback.
Of note, failures occurring early after implantation of a single clip may in part remind of a technically imperfect edge-to-edge execution, whereas the more delayed recurrence of MR observed after implantation of 2 clips resembles the results of an adequate edge-to-edge repair, limited by the absence of annuloplasty. Indeed, annular dilation represents an important pathological mechanism in most cases of MR that is not addressed by the MitraClip procedure. Annuloplasty is a well-recognized fundamental step of surgical mitral repair, the absence of which is associated with an increased rate of MR recurrence, even with the edge-to-edge repair [11] .
In surgery, other than improving leaflet coaptation and preventing further annulus enlargement, annuloplasty is key because the dilation of the septolateral annular dimension increases edge-to-edge stitch tension [12] [13] [14] and can therefore adversely affect the durability of the repair if concomitant ring annuloplasty is not performed. This mechanism is likely to happen even with the MitraClip, with PCD and leaflet tears. In this regard, the addition of a second clip may help to reduce the tension between the clips and the leaflets. Maybe, in the near future, the addition of a percutaneous ring providing septolateral annular reduction [15] and reducing leaflet stress may allow a single clip to provide more durable results.
It should be also remembered that FMR is mainly a ventricular disease, in which left ventricular baseline dilation and follow-up remodelling, strictly linked to the underlying ventricular disease, are significantly associated with the recurrence of MR [16, 17] .
The reduction of MVA following the implantion of a second clip obviously warrants careful consideration to avoid development of critical mitral stenosis. Indeed, not all patients can receive multiple clips. In our experience, approximately one-third of patients with 2 clips ended the procedure with an MVA <2.5 cm 2 . In our small series, this result was not associated with the clear impairment of any clinical outcome (overall death, cardiac death, heart failure and NYHA Class). Nevertheless, we acknowledge that mitral stenosis must be ruled out before inserting more than 1 clip. This decision should take into account not only numerical echocardiographic paramenters but also the patient's age and lifestyle. These factors would become increasingly important if indications for use of the MitraClip change to include younger, lower risk patients. In these patients, mitral stenosis after the MitraClip procedure warrants particularly high caution because it would be even more difficult to treat than the patient's baseline MR. Indeed, clips cannot be removed percutaneously after deployment; they may prevent the application of other percutaneous treatments (such as implantation of mitral prostheses); and they are not easily removed surgically without compromising a subsequent mitral repair [18] .
It is important to stress the key role of the appropriate selection of patients for the MitraClip procedure. In this study, we found a 2-year 100% freedom from MR recurrence in DMR patients treated with 2 clips, a 'surgical-like' best ever reported result in any MitraClip series. The numbers are small, the followup is short and the group is highly selected. Still, we believe this finding is encouraging: when patients are selected appropriately preoperatively, and the operation is well-performed technically, good acute results and promising follow-up durability may indeed be achieved. To better understand the patient selection process in order to achieve a good reduction in MR is an urgent, unmet need, because precise data are still lacking. Based on personal experience, we barely know which valves provide a good short-term result (narrow jets, narrow lesions and no annular dilation). To know which valves will be durable over the long term is a more distant target. Hopefully, data from large registries developed in the coming years will help.
As surgeons, we must also improve our understanding of how best to treat patients technically. We know from surgery that, together with annuloplasty, learning how to optimize the 'leaflet repair' is fundamental to achieving better efficacy and durability of transcatheter mitral repair. This knowledge is particularly important in the perspective of (i) the future expansion of transcatheter mitral techniques to younger, lower risk patients and (ii) the current development of transcatheter mitral replacement [19] that promises to easily solve every residual MR issue. The debate as to whether a good percutaneous repair would be better than a good percutaneous replacement is now open. We believe that the percutaneous edge-to-edge technique will remain on the scene for a long time, thanks to its simplicity and its versatility, provided that better efficacy is achieved through careful patient selection and conscientious use of the device.
Study limitations
We acknowledge this study has some limitations. Most important, it was not prospectively conducted or randomized. Instead, it was a retrospective review of a relatively small cohort of patients. Therefore, possible patient selection biases in terms of both clinical and anatomical features must be acknowledged. Indeed the single clip and 2 clips groups differed in several characteristics, but propensity matching could also not be performed due to the small number of available patients, especially since FMR and DMR were analysed separately. Also, on the basis of our personal experience over time, we now implant more than 1 clip in the majority of our patients because we believe it improves procedural efficacy. Unfortunately, precise data regarding eligibility for a second clip, the reason for a second clip and issues following implant of a second clip were not available for all patients of this series. Notably, the small number of patients may have impaired the statistical power, especially in the DMR group. Lastly, precise descriptions of the mechanisms of MR recurrence were not available for all patients.
Given all of these limitations, the present study has to be considered hypothesis generating. We can only raise a word of caution regarding the durability of mitral repair with a single clip and the opportunity of adding a second clip in patients who can receive it. To fully rule out any bias in patient selection and treatment, a prospective randomized study comparing truly similar groups in terms of patient numbers, clinical features and anatomical features would be required. Otherwise, larger retrospective registries are needed to confirm our findings and to improve our knowledge of how to optimize the efficacy and the durability of mitral repair with the percutaneous edge-to-edge technique.
CONCLUSIONS
Despite favourable baseline anatomical features and an optimal initial result, the implant of a single clip was associated with an increased recurrence of MR during the follow-up period compared with implanting 2 clips, both in FMR and in DMR. A single clip implant should be done with caution in patients who are eligible for a second clip, especially in younger, lower risk patients. Although more data are needed to ultimately confirm this finding, together with careful patient selection, better technical performance should be achieved to improve the durability of transcatheter mitral repair.
